[RCUS] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[RCUS] Arcus Biosciences, Inc.
Announcement Date
30-Dec-2017
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- 42.87%
YoY-
Quarter Report
RCUS's Result
RCUS's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 31,000 345 354,499 9,487 9,750 1,562 1,250 70.72%
PBT -80,000 -67,000 281,183 -51,853 -16,598 -12,295 -13,210 34.99%
Tax 1,000 -4 1,815 -1,820 -856 -2,459 0 -
NP -81,000 -66,996 279,368 -51,853 -16,598 -12,295 -13,210 35.27%
Tax Rate - - -0.65% - - - - -
Total Cost 112,000 67,341 75,131 61,340 26,348 13,857 14,460 40.63%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -261.29 -19,419.13 78.81 -546.57 -170.24 -787.13 -1,056.80 -20.76%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -1.08 -0.92 3.97 -0.82 -0.38 -0.28 -0.54 12.24%
EPS Diluted -1.08 -0.92 3.71 -0.82 -0.38 -0.28 -0.54 12.24%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.